Can herpes cause hair loss? It is a question that concerns many people who experience scalp symptoms during or after a herpes outbreak. Herpes viruses — particularly herpes zoster (shingles) — can affect the scalp, triggering inflammation that may temporarily disrupt hair growth. In rare cases, scarring from a shingles outbreak can lead to more lasting follicular damage. Understanding the relationship between herpes infections and hair loss, the types of virus involved, and when to seek medical advice is essential for anyone experiencing these symptoms.

How Herpes Infections Can Affect the Scalp and Hair Follicles

Herpes outbreaks on the scalp cause inflammation that can disrupt the hair growth cycle, pushing follicles into the telogen phase and causing temporary hair loss; permanent scarring alopecia is rare and mainly associated with herpes zoster.

Not sure if this is normal? Chat with one of our pharmacists →

Herpes viruses are a family of DNA viruses capable of infecting a wide range of tissues, including the skin and, in some cases, the scalp. When a herpes outbreak occurs on or near the scalp, the resulting inflammation, blistering, and crusting can temporarily disrupt the local skin environment. Typical lesions appear as grouped vesicles on an erythematous (red) base, which may crust over and, if secondarily infected with bacteria, can worsen local tissue damage and increase the risk of hair loss.

Hair follicles are sensitive structures embedded within the dermis, and significant inflammation in their immediate vicinity can interfere with the normal hair growth cycle. The hair growth cycle consists of three main phases: anagen (active growth), catagen (transition), and telogen (resting and shedding). Inflammatory conditions — including viral infections — can prematurely push follicles into the telogen phase, a process known as telogen effluvium. This type of hair loss is typically diffuse and temporary, often resolving once the underlying trigger is treated or resolves naturally. The British Association of Dermatologists (BAD) patient information on telogen effluvium confirms that most cases resolve spontaneously.

In cases where a herpes zoster (shingles) outbreak affects the scalp, post-herpetic scarring alopecia has been documented in case reports and small case series, though it remains uncommon. By contrast, permanent follicular damage following herpes simplex virus (HSV) infection is very rarely reported. It is important to note that not all herpes infections affect the scalp, and hair loss directly attributable to herpes is relatively rare compared with other dermatological causes.

If you develop a painful blistering rash on the scalp — particularly one affecting one side of the face or near the eye — seek same-day medical advice, as this may indicate shingles requiring prompt treatment.

Types of Herpes Linked to Hair Loss and Scalp Symptoms

Herpes zoster is the most clinically relevant virus for scalp hair loss; HSV-1 can rarely cause herpetic folliculitis, while EBV and CMV may trigger indirect telogen effluvium through systemic illness.

The herpes virus family includes several strains, but two are most clinically relevant when discussing scalp involvement and potential hair loss:

• Herpes zoster (shingles): Caused by reactivation of the varicella-zoster virus (VZV), shingles can affect the scalp when the trigeminal or cervical nerve dermatomes are involved. The characteristic painful, blistering rash can extend across the scalp and, in some cases, lead to localised hair loss — either temporary due to inflammation or, rarely, permanent if scarring (cicatricial alopecia) occurs, as documented in dermatological case reports. When shingles affects the area around the eye (herpes zoster ophthalmicus), this is a medical emergency requiring same-day assessment, ideally including ophthalmology review, as vision may be at risk.

• Herpes simplex virus (HSV-1 and HSV-2): HSV-1 most commonly causes oral and facial cold sores, and outbreaks near the hairline or on the scalp are possible, though less frequent. A rare presentation called herpetic folliculitis — where HSV infects hair follicles directly — has been described; diagnosis can be supported by PCR swab of lesion fluid if there is clinical uncertainty. HSV-2, primarily associated with genital herpes, very rarely affects the scalp.

Of these, herpes zoster is the more commonly implicated virus in scalp-related hair loss. It should be noted that folliculitis decalvans — a scarring alopecia typically associated with bacterial colonisation — is a distinct condition with no established causal link to herpes infection; any suggestion of an association in older literature is unconfirmed and should not be inferred.

It is also worth noting that cytomegalovirus (CMV) and Epstein-Barr virus (EBV), both members of the herpes family, have been associated with systemic hair loss (telogen effluvium) following acute illness. This is an indirect effect of systemic illness rather than direct follicular infection, and is not specific to herpes-family viruses.

What the Medical Evidence Says About Herpes and Hair Loss

Evidence linking herpes to hair loss is limited to case reports and small case series; post-herpetic alopecia is documented for shingles, but no established link exists between HSV infection and significant hair loss.

The direct relationship between herpes infections and hair loss is not firmly established in large-scale clinical trials, and it is important to approach this topic with appropriate nuance. Most of the available evidence comes from case reports and small case series rather than robust randomised controlled studies; the overall evidence base is therefore considered low-level.

For herpes zoster affecting the scalp, case reports and dermatological case series describe localised hair loss — sometimes referred to as post-herpetic alopecia — occurring within the affected dermatome. Proposed (but not proven) mechanisms include direct viral damage to the hair follicle itself or to the nerve supply that supports follicular function. Some case reports have documented hair regrowth following resolution of the outbreak, though it is not possible to attribute this to antiviral treatment specifically, as regrowth may occur naturally once inflammation subsides regardless of treatment.

For herpes simplex, there is no established link between HSV infection and significant hair loss in the peer-reviewed literature. Any hair loss associated with an HSV outbreak on the scalp is more likely attributable to localised inflammation or secondary bacterial infection rather than direct viral follicular damage.

Systemic illness caused by any herpes-family virus — particularly EBV (infectious mononucleosis, or glandular fever) — can trigger telogen effluvium, a well-recognised form of diffuse, temporary hair shedding that typically begins two to three months after the triggering illness. This is a stress response of the hair cycle and is not specific to herpes viruses. In most cases, hair regrowth occurs naturally within six to twelve months without specific treatment, as outlined in BAD patient information on telogen effluvium.

Other Causes of Hair Loss Worth Ruling Out

Common causes including androgenetic alopecia, telogen effluvium, alopecia areata, and tinea capitis must be excluded before attributing hair loss to herpes, as the link is not firmly established for most presentations.

Because the link between herpes and hair loss is not firmly established for most presentations, it is clinically important to consider and exclude other common causes before attributing hair loss to a herpes infection. Hair loss is a symptom with a broad differential diagnosis, and accurate identification of the underlying cause is essential for appropriate management.

Common causes to consider include:

• Androgenetic alopecia: The most prevalent form of hair loss in both men and women, driven by genetic and hormonal factors.

• Telogen effluvium: Diffuse shedding triggered by physical or emotional stress, nutritional deficiencies, thyroid dysfunction, or recent illness.

• Alopecia areata: An autoimmune condition causing patchy hair loss. Viral infections have been proposed as possible triggers, though a causal relationship has not been proven. Assessment and referral guidance is available via NICE CKS: Alopecia areata and BAD patient resources.

• Tinea capitis: A fungal scalp infection that can mimic some features of viral scalp disease and cause hair loss, particularly in children. Suspected tinea capitis warrants prompt GP assessment, as oral antifungal treatment is required and specialist referral may be needed.

• Scarring alopecias: Conditions such as lichen planopilaris or discoid lupus erythematosus that cause permanent follicular destruction.

• Medication-related hair changes: Some medicines can affect hair growth. If you are concerned that a medication may be contributing to hair loss, speak to your GP or pharmacist. Any suspected side effects from medicines — including antivirals — should be reported via the MHRA Yellow Card Scheme (available at yellowcard.mhra.gov.uk).

A thorough history and clinical examination are the foundation of assessment. Where clinically indicated — based on the history and examination findings — a GP may consider targeted investigations such as a full blood count, ferritin, or thyroid function tests. Routine testing of all patients is not universally recommended; the choice of investigations should be guided by individual clinical suspicion, in line with NHS and NICE-aligned practice.

When to See a GP or Dermatologist About Hair Loss

Seek same-day advice for a painful blistering scalp rash, especially near the eye, as this may indicate herpes zoster ophthalmicus; see a GP promptly for sudden, patchy, or post-illness hair loss.

Knowing when to seek professional advice is important for both timely diagnosis and appropriate reassurance. Not all hair loss requires urgent medical attention, but certain features should prompt a consultation with a GP or dermatologist without delay.

Seek a GP appointment if you notice:

• Sudden or rapidly progressive hair loss over a period of weeks

• Patchy hair loss, particularly if associated with scalp redness, scaling, blistering, or pain

• Hair loss following a recent illness, including a confirmed or suspected herpes outbreak

• Associated symptoms such as fatigue, weight changes, or skin changes elsewhere on the body

• Hair loss that is causing significant psychological distress

Seek urgent or same-day advice if:

• You develop a painful blistering rash on the scalp, particularly if it affects one side of the face — this may indicate herpes zoster (shingles) and requires prompt antiviral treatment, ideally within 72 hours of rash onset, in line with NICE CKS guidance on shingles

• The rash involves or is near the eye or tip of the nose — this may indicate herpes zoster ophthalmicus, which requires same-day assessment and urgent ophthalmology review to protect vision

• You are pregnant, immunocompromised (for example, due to HIV, chemotherapy, or immunosuppressant medicines), or have severe pain or systemic symptoms — these groups require urgent assessment as antiviral treatment may be indicated even beyond the standard 72-hour window, and specialist input may be needed

• There are signs of secondary bacterial infection, such as increasing redness, warmth, swelling, or discharge

Children with suspected tinea capitis should be seen promptly by a GP, as oral antifungal treatment is required and referral to a dermatologist may be appropriate.

A GP can perform an initial assessment and, where appropriate, refer to a dermatologist for specialist evaluation, including dermoscopy or scalp biopsy if a scarring alopecia is suspected. Early referral is particularly important when scarring is a possibility, as prompt treatment may help preserve remaining follicles.

Treatment Options Available Through the NHS

NHS treatment depends on the cause: antivirals for shingles or HSV, watchful waiting for post-viral telogen effluvium, and topical or intralesional corticosteroids for alopecia areata, with JAK inhibitors available via specialist pathways for severe cases.

Treatment for hair loss associated with herpes infections depends on the underlying cause and the type of herpes virus involved. The NHS provides a range of options through both primary and secondary care pathways.

For herpes zoster (shingles) affecting the scalp:

• Antiviral medication — aciclovir, valaciclovir, or famciclovir — is the first-line treatment and is most effective when started within 72 hours of rash onset, in line with NICE CKS guidance on shingles. These medicines work by inhibiting viral DNA polymerase, thereby reducing viral replication and limiting tissue damage. In people who are immunocompromised or who have severe disease, intravenous aciclovir in a secondary care setting may be required.

• Where new vesicles are still appearing, or in high-risk groups (including those who are immunocompromised or pregnant), antiviral treatment may still be considered beyond 72 hours — discuss this with a GP or specialist promptly.

• Pain management with analgesics or neuropathic agents (such as amitriptyline or gabapentin) may be required for post-herpetic neuralgia, as outlined in NICE CKS guidance.

• If hair loss occurs following a shingles outbreak, a watchful waiting approach is often appropriate, as regrowth frequently occurs once inflammation resolves.

For HSV affecting the scalp:

• Oral antiviral treatment with aciclovir or valaciclovir, at doses appropriate for HSV infection as per BNF guidance, may be prescribed by a GP.

For telogen effluvium following viral illness:

• Where investigations confirm a nutritional deficiency (such as low ferritin or vitamin D), targeted supplementation to correct the documented deficiency is appropriate. Routine supplementation without confirmed deficiency is not recommended.

• Reassurance and monitoring are central to management, as spontaneous recovery is the norm.

For alopecia areata triggered or worsened by infection:

• NICE-aligned options include topical corticosteroids and intralesional steroid injections. In more extensive or treatment-resistant cases, referral for specialist therapies is appropriate. JAK inhibitors — including baricitinib and ritlecitinib — are available through NHS specialist pathways for severe alopecia areata, subject to eligibility criteria defined in the relevant NICE Technology Appraisals; these medicines are initiated and supervised by specialists.

Prevention:

• The shingles vaccine is available on the NHS for eligible age groups and certain at-risk individuals. Vaccination reduces the risk and severity of shingles and its complications, including post-herpetic neuralgia and scalp involvement. Speak to your GP or pharmacist about eligibility, or visit the NHS website for up-to-date information on the shingles vaccination programme.

Patients are encouraged to discuss all treatment options with their GP or dermatologist, as individual suitability varies. If you experience any suspected side effects from medicines used to treat herpes or hair loss, please report these via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk). The NHS also provides access to psychological support for those experiencing significant distress related to hair loss, recognising the considerable impact it can have on quality of life.

Experiencing these side effects? Our pharmacists can help you navigate them →

Frequently Asked Questions